Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Black Diamond Therapeutics (BDTX) Short term Debt (2018 - 2020)

Black Diamond Therapeutics' Short term Debt history spans 2 years, with the latest figure at $190000.0 for Q3 2020.

  • For Q3 2020, Short term Debt changed N/A year-over-year to $190000.0; the TTM value through Sep 2020 reached $190000.0, changed N/A, while the annual FY2018 figure was $1.7 million, N/A changed from the prior year.
  • Short term Debt reached $190000.0 in Q3 2020 per BDTX's latest filing, up from $15000.0 in the prior quarter.
  • In the past five years, Short term Debt ranged from a high of $1.7 million in Q4 2018 to a low of $15000.0 in Q2 2020.